Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 383


 
 Table of Contents  
CASE REPORT
Year : 2014  |  Volume : 6  |  Issue : 11  |  Page : 599-600

Perforated jejunal diverticulum in the use of mycophenolate mofetil


1 Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA
2 SUNY Upstate Medical University, Syracuse, New York, USA
3 Department of Medicine, Bassett Medical Center, Cooperstown, New York, USA

Date of Web Publication26-Nov-2014

Correspondence Address:
Wisit Cheungpasitporn
Mayo Clinic, Rochester, Minnesota- 55905
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1947-2714.145484

Rights and Permissions
  Abstract 

Context: Jejunal diverticulosis is a rare disease. Common acute complications include diverticulitis, intestinal obstruction, bleeding and perforation. Gastrointestinal tract perorations have also been rarely observed in the use of mycophenolate mofetil. Case Report: We report a 44-year-old man with end-stage renal disease post failed kidney transplant on low-dose mycophenolate mofetil who presented with acute onset of abdominal pain. He was successfully given the diagnosis of perforated jejunal diverticulum. The patient successfully underwent a segmental jejunal resection and anastomosis. He unfortunately developed a recurrent jejunal perforation a month later and again had the second segmental jejunal resection operation. Mycophenolate mofetil then was discontinued. Conclusion: The present case illustrates jejunal diverticulum perforation in the use of mycophenolate mofetil. Physicians should increase the awareness of this association of perforated jejunal diverticulum in patients using mycophenolate mofetil.

Keywords: Intestinal perforation, immunosuppression, jejunal diverticulosis


How to cite this article:
Thongprayoon C, Cheungpasitporn W, Edmonds PJ, Thamcharoen N. Perforated jejunal diverticulum in the use of mycophenolate mofetil. North Am J Med Sci 2014;6:599-600

How to cite this URL:
Thongprayoon C, Cheungpasitporn W, Edmonds PJ, Thamcharoen N. Perforated jejunal diverticulum in the use of mycophenolate mofetil. North Am J Med Sci [serial online] 2014 [cited 2019 Nov 20];6:599-600. Available from: http://www.najms.org/text.asp?2014/6/11/599/145484


  Introduction Top


Perforated jejunal diverticulum is a very rare disease. [1] Gastrointestinal tract perorations have also been rarely observed in the use of mycophenolate mofetil. We report a case of recurrentperforated jejunal diverticulum in a patient with end-stage renal disease (ESRD) post failed kidney transplant on low-dose mycophenolate mofetil. Physicians should increase the awareness of this association of jejunal diverticulum perforation in patients using mycophenolate mofetil.


  Case Presentation Top


A 44-year-old man presented to the emergency department with acute onset of abdominal pain. He reported that his pain started 2 days ago and had become progressively worse. The pain was diffuse across his mid-to-lower abdomen. The patient had normal bowel movements and denied any fever, chills, nausea, or vomiting. His medical history was significant for end-stage renal disease (ESRD) from his congenital renal hypoplasia. He received kidney transplant 7 years ago. Unfortunately, he developed acute antibody rejection and had been requiring intermittent hemodialysis for the past 2 years. He desired to undergo renal transplant again and had been on immunosuppression with oral prednisone (5 mg/day) and mycophenolate mofetil (250 mg/day). On physical examination, the patient had a blood pressure of 105/60, heart rate of 103, respiratory rate of 20, body temperature 37.1°C. His abdominal examination demonstrated generalized tenderness. There was remarkable lower abdomen rebound tenderness, just below the level of the umbilicus. Bowel sound was absent. Computed tomography (CT) of the abdomen and pelvis with intravenous (IV) contrast was performed [Figure 1] and [Figure 2].
Figure 1: Abdominal CT (axial view) demonstrated ruptured jejunal diverticulum with associated free intraperitoneal air (white arrows) and surrounding mesenteric edema left mid abdomen

Click here to view
Figure 2: Abdominal CT (coronal view) demonstrated ruptured jejunal diverticulum with associated free intraperitoneal air (white arrows) and surrounding mesenteric edema left mid abdomen

Click here to view


Abdominal CT (axial view, [Figure 1] and coronal, [Figure 2] demonstrated ruptured jejunal diverticulum with associated free intraperitoneal air (white arrows) and surrounding mesenteric edema left mid abdomen. Numerous small bowel diverticuli were noted with marked jejunal diverticulosis. The patient underwent a segmental jejunal resection and anastomosis. His postoperative course was uneventful. The patient was dismissed from the hospital and continued his immunosuppression, including prednisone and mycophenolate mofetil. A month later after his hospitalization, the patient appeared with the same presentation and was found to have recurrent jejunal diverticulum perforation. He again underwent a segmental jejunal resection and anastomosis. Nephrology was consulted. The information on the risks and benefits of mycophenolate mofetil as well as information on alternative options such as azathioprine was provided. Mycophenolate mofetil was discontinued. Three months after hospitalization, the patient continued to do well without any further episode of abdominal pain.


  Discussion Top


Jejunal diverticulosis is a rare disease with an incidence of less than 0.5%. [1] Most cases of jejunal diverticulosis are usually asymptomatic. Common acute complications include diverticulitis, intestinal obstruction, bleeding and perforation.

If the perforated jejunal diverticulum causes only localized peritonitis and the patient has stable hemodynamics, non-surgical management with intravenous antibiotics and percutaneous CT-guided aspiration of localized intraperitoneal collections are possible treatment options. [2] However, the current treatment of choice for perforated jejunal diverticulum with generalized peritonitis is urgent laparotomy with segmental intestinal resection and primary anastomosis.

In our case, due to immunosuppression, the patient underwent a segmental jejunal resection and anastomosis. Since gastrointestinal tract perorations have been rarely observed in the use of mycophenolate mofetil, [3] the patient was informed and planned for closed follow-up.

 
  References Top

1.
Zager JS, Garbus JE, Shaw JP, Cohen MG, Garber SM. Jejunal diverticulosis: A rare entity with multiple presentations, a series of cases. Dig Surg 2000;17:643-5.  Back to cited text no. 1
    
2.
Novak JS, Tobias J, Barkin JS. Nonsurgical management of acute jejunal diverticulitis: A review. Am J Gastroenterol 1997;92:1929-31.  Back to cited text no. 2
    
3.
Catena F, Ansaloni L, Gazzotti F, Bertelli R, Severi S, Coccolini F, et al. Gastrointestinal perforations following kidney transplantation. Transplant Proc 2008;40:1895-6.  Back to cited text no. 3
    


    Figures

  [Figure 1], [Figure 2]


This article has been cited by
1 Mycophenolate mofetil
Reactions Weekly. 2015; 1544(1): 166
[Pubmed] | [DOI]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract
Introduction
Case Presentation
Discussion
References
Article Figures

 Article Access Statistics
    Viewed1154    
    Printed41    
    Emailed0    
    PDF Downloaded197    
    Comments [Add]    
    Cited by others 1    

Recommend this journal